BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mok MY, Lau CS, Chiu SSH, Tso AWK, Lo Y, Law LSC, Mak KF, Wong WS, Khong PL, Lam KSL. Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition. Arthritis & Rheumatism 2011;63:1387-95. [DOI: 10.1002/art.30283] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Nicoll R, Henein M. Arterial calcification: A new perspective? International Journal of Cardiology 2017;228:11-22. [DOI: 10.1016/j.ijcard.2016.11.099] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 5.6] [Reference Citation Analysis]
2 Soriano A, Afeltra A, Shoenfeld Y. Is atherosclerosis accelerated in systemic sclerosis? Novel insights. Current Opinion in Rheumatology 2014;26:653-7. [DOI: 10.1097/bor.0000000000000115] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
3 Desai CS, Lee DC, Shah SJ. Systemic sclerosis and the heart: current diagnosis and management. Curr Opin Rheumatol 2011;23:545-54. [PMID: 21897256 DOI: 10.1097/BOR.0b013e32834b8975] [Cited by in Crossref: 57] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
4 Yiu KH, Tse HF, Mok MY, Lau CS. Ethnic differences in cardiovascular risk in rheumatic disease: focus on Asians. Nat Rev Rheumatol 2011;7:609-18. [PMID: 21912432 DOI: 10.1038/nrrheum.2011.126] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
5 Long BD, Stojanovska J, Brown RKJ, Attili AK, Jackson EA, Ognenovski V. Increased Epicardial Fat Volume Is Independently Associated with the Presence and Severity of Systemic Sclerosis. Acad Radiol 2017;24:1473-81. [PMID: 28847640 DOI: 10.1016/j.acra.2017.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
6 Ferraz-Amaro I, Delgado-Frías E, Hernández-Hernández V, Sánchez-Pérez H, de Armas-Rillo L, Armas-González E, Machado JD, Diaz-González F. HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis. Arthritis Res Ther 2021;23:62. [PMID: 33622410 DOI: 10.1186/s13075-021-02443-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Becker MO, Riemekasten G. [Critical limb ischemia in systemic sclerosis]. Z Rheumatol 2012;71:261-9. [PMID: 22538844 DOI: 10.1007/s00393-011-0914-3] [Reference Citation Analysis]
8 Pagkopoulou E, Arvanitaki A, Daoussis D, Garyfallos A, Kitas G, Dimitroulas T. Comorbidity burden in systemic sclerosis: beyond disease-specific complications. Rheumatol Int 2019;39:1507-17. [PMID: 31300848 DOI: 10.1007/s00296-019-04371-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Small HY, Migliarino S, Czesnikiewicz-guzik M, Guzik TJ. Hypertension: Focus on autoimmunity and oxidative stress. Free Radical Biology and Medicine 2018;125:104-15. [DOI: 10.1016/j.freeradbiomed.2018.05.085] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 12.3] [Reference Citation Analysis]
10 Angeloudi E, Pagkopoulou E, Arvanitaki A, Soulaidopoulos S, Garyfallos A, Kitas G, Dimitroulas T. Cardiovascular Risk in Systemic Sclerosis. Curr Treat Options in Rheum 2020;6:282-98. [DOI: 10.1007/s40674-020-00152-z] [Reference Citation Analysis]
11 Ali H, Ng KR, Low AH. A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis. Int J Rheum Dis 2015;18:276-86. [PMID: 25884668 DOI: 10.1111/1756-185X.12566] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
12 Farshad S, Halalau A, Townsend W, Schiopu E. Utility of Coronary Calcium Scoring (CCS) in Connective Tissue Disorders (CTDs) for the Evaluation of Subclinical Coronary Atherosclerosis - A Systematic Review. ACR Open Rheumatol 2020;2:84-91. [PMID: 32043830 DOI: 10.1002/acr2.11107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Man A, Zhu Y, Zhang Y, Dubreuil M, Rho YH, Peloquin C, Simms RW, Choi HK. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 2013;72:1188-93. [PMID: 22904260 DOI: 10.1136/annrheumdis-2012-202007] [Cited by in Crossref: 77] [Cited by in F6Publishing: 61] [Article Influence: 7.7] [Reference Citation Analysis]
14 Frerix M, Stegbauer J, Kreuter A, Weiner SM. Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events. Arthritis Res Ther 2014;16:R54. [PMID: 24548804 DOI: 10.1186/ar4489] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
15 El Hasbani G, Viola M, Sciascia S, Taher AT, Uthman I. Antiphospholipid Antibodies in Inflammatory and Autoimmune Rheumatic and Musculoskeletal Diseases Beyond Lupus: A Systematic Review of the Available Evidence. Rheumatol Ther 2021;8:81-94. [PMID: 33420626 DOI: 10.1007/s40744-020-00273-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Durante A, Bronzato S. The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations. J Clin Med Res 2015;7:379-84. [PMID: 25883699 DOI: 10.14740/jocmr2122w] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
17 Yiu KH, Yeung CK, Zhao CT, Chan JC, Siu CW, Tam S, Wong CS, Yan GH, Yue WS, Khong PL. Prevalence and extent of subclinical atherosclerosis in patients with psoriasis. J Intern Med. 2013;273:273-282. [PMID: 23003220 DOI: 10.1111/joim.12002] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
18 Rangarajan V, Matiasz R, Freed BH. Cardiac complications of systemic sclerosis and management: recent progress. Current Opinion in Rheumatology 2017;29:574-84. [DOI: 10.1097/bor.0000000000000439] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
19 Fairweather D, Petri MA, Coronado MJ, Cooper LT. Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol 2012;8:269-84. [PMID: 22390491 DOI: 10.1586/eci.12.10] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
20 Hung G, Mercurio V, Hsu S, Mathai SC, Shah AA, Mukherjee M. Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis. Curr Rheumatol Rep 2019;21. [DOI: 10.1007/s11926-019-0867-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
21 Sanz Pérez I, Martínez Valle F, Guillén-del-castillo A, Roque Pérez A, Cuéllar Calàbria H, Pizzi M, Fernández Codina A, Callejas-moraga E, Orozco Gálvez O, Fonollosa Pla V, Simeón Aznar C. Subclinical cardiovascular disease and Systemic Sclerosis: A comparison between risk charts, quantification of coronary calcium and carotid ultrasonography. Autoimmunity Reviews 2018;17:900-5. [DOI: 10.1016/j.autrev.2018.03.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
22 Aviña-zubieta JA, Man A, Yurkovich M, Huang K, Sayre EC, Choi HK. Early Cardiovascular Disease After the Diagnosis of Systemic Sclerosis. The American Journal of Medicine 2016;129:324-31. [DOI: 10.1016/j.amjmed.2015.10.037] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
23 Ruffenach G, Chabot S, Tanguay VF, Courboulin A, Boucherat O, Potus F, Meloche J, Pflieger A, Breuils-bonnet S, Nadeau V, Paradis R, Tremblay E, Girerd B, Hautefort A, Montani D, Fadel E, Dorfmuller P, Humbert M, Perros F, Paulin R, Provencher S, Bonnet S. Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med 2016;194:1273-85. [DOI: 10.1164/rccm.201512-2380oc] [Cited by in Crossref: 51] [Cited by in F6Publishing: 29] [Article Influence: 8.5] [Reference Citation Analysis]
24 Ozen G, Inanc N, Unal AU, Korkmaz F, Sunbul M, Ozmen M, Akar S, Deniz R, Donmez S, Pamuk ON, Atagunduz P, Tigen K, Direskeneli H. Subclinical Atherosclerosis in Systemic Sclerosis: Not Less Frequent Than Rheumatoid Arthritis and Not Detected With Cardiovascular Risk Indices: Atherosclerosis and Cardiovascular Risk Assessment in Systemic Sclerosis. Arthritis Care & Research 2016;68:1538-46. [DOI: 10.1002/acr.22852] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
25 Parks JL, Taylor MH, Parks LP, Silver RM. Systemic sclerosis and the heart. Rheum Dis Clin North Am. 2014;40:87-102. [PMID: 24268011 DOI: 10.1016/j.rdc.2013.10.007] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
26 Cannarile F, Valentini V, Mirabelli G, Alunno A, Terenzi R, Luccioli F, Gerli R, Bartoloni E. Cardiovascular disease in systemic sclerosis. Ann Transl Med 2015;3:8. [PMID: 25705640 DOI: 10.3978/j.issn.2305-5839.2014.12.12] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
27 Ross L, Paratz E, Baron M, La Gerche A, Nikpour M. Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management. Diagnostics (Basel) 2021;11:1781. [PMID: 34679479 DOI: 10.3390/diagnostics11101781] [Reference Citation Analysis]
28 Pacholczak-Madej R, Kuszmiersz P, Bazan-Socha S, Kosałka-Wêgiel J, Iwaniec T, Zarêba L, Kielczewski S, Rams A, Walocha JA, Musiał J, Dropiñski J. Endothelial dysfunction in patients with systemic sclerosis. Postepy Dermatol Alergol 2020;37:495-502. [PMID: 32994769 DOI: 10.5114/ada.2019.83501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Kakuta K, Dohi K, Sato Y, Yamanaka T, Kawamura M, Ogura T, Nakamori S, Fujimoto N, Fujii E, Yamada N, Ito M. Chronic Inflammatory Disease Is an Independent Risk Factor for Coronary Flow Velocity Reserve Impairment Unrelated to the Processes of Coronary Artery Calcium Deposition. J Am Soc Echocardiogr 2016;29:173-80. [PMID: 26443046 DOI: 10.1016/j.echo.2015.09.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
30 Sobanski V, Lemaire-Olivier A, Giovannelli J, Dauchet L, Simon M, Lopez B, Yelnik C, Lambert M, Hatron PY, Hachulla E, Dubucquoi S, Launay D. Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis. Front Immunol 2018;9:2457. [PMID: 30464761 DOI: 10.3389/fimmu.2018.02457] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
31 Amaya-Amaya J, Montoya-Sánchez L, Rojas-Villarraga A. Cardiovascular involvement in autoimmune diseases. Biomed Res Int 2014;2014:367359. [PMID: 25177690 DOI: 10.1155/2014/367359] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
32 Ryan BJ, Nissim A, Winyard PG. Oxidative post-translational modifications and their involvement in the pathogenesis of autoimmune diseases. Redox Biol. 2014;2:715-724. [PMID: 24955328 DOI: 10.1016/j.redox.2014.05.004] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 7.8] [Reference Citation Analysis]